Wang et al. [90] confirmed that upregulated PYCR1 promoted the progression of NSCLC by activating the mitogen-activated protein kinase 13 (p38) pathway, while it was suppressed by microRNA-488 (miR-488). The gene discussed is MAPK13; the disease is non-small cell lung carcinoma.